{"id":"W4408167066","doi":"10.1200/jco-24-01283","title":"Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval; Lakeridge Health","funders":"","keywords":"Docetaxel; Medicine; Prostate cancer; Pembrolizumab; Oncology; Double blind; Internal medicine; Randomized controlled trial; Prostate; Urology; Chemotherapy; Cancer; Placebo; Pathology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007632824,0.0003508369,0.003677512,0.0002946616,0.0002651063,0.00007844035,0.0003679494,0.0003187582,0.0001446074],"category_scores_gemma":[0.003812258,0.0001803926,0.00163498,0.0004654413,0.0007820894,0.0001914865,0.00006339366,0.001185709,0.000006091728],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007908628,"about_ca_system_score_gemma":0.01220178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002718216,"about_ca_topic_score_gemma":0.000338172,"domain_scores_codex":[0.9931151,0.001115138,0.004063819,0.0004103066,0.0006765139,0.0006191827],"domain_scores_gemma":[0.9863105,0.009105715,0.00235548,0.0003860869,0.001400432,0.0004417668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9503826,0.002694886,0.00003563565,0.0001564269,0.005474749,0.0003629493,0.0002772531,0.00007954029,0.00008291646,0.0005728866,0.004850109,0.03503009],"study_design_scores_gemma":[0.9420006,0.02320031,0.00004630575,0.0002262597,0.006997623,0.00005043595,0.0002467312,0.0006650474,0.0003162693,0.000527175,0.02557813,0.000145163],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9377541,0.01122244,0.0004280974,0.03091814,0.004516872,0.01222967,0.00007265011,0.00003137779,0.002826632],"genre_scores_gemma":[0.9759859,0.0106578,0.0007771521,0.0007717454,0.001731889,0.001352454,0.00005985445,0.0000395388,0.008623692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03823176,"threshold_uncertainty_score":0.9933981,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2509900570005083,"score_gpt":0.551990400322006,"score_spread":0.3010003433214977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}